Jump to content

USApedia

Template:Regulation of therapeutic goods in the United States: Difference between revisions

From USApedia

Revision as of 09:26, 12 May 2023

Regulation of therapeutic goods in the United States
File:Ritalin-SR-20mg-1000x1000.jpg
Prescription drugs Over-the-counter drugs
Law Federal Food, Drug, and Cosmetic Act CDAPCA Controlled Substances Act Prescription Drug Marketing Act Hatch-Waxman Act exemptions Marihuana Tax Act of 1937
Government agencies Department of Health and Human Services Food and Drug Administration Department of Justice DEA
Process Drug discovery Drug design Drug development New Drug Application Investigational New Drug Clinical trial phases Randomized controlled trial Pharmacovigilance Abbreviated New Drug Application Fast track approval Off-label use
International coordination ICH Uppsala Monitoring Centre WHO CIOMS Single Convention on Narcotic Drugs
Non-governmental organizations National Academy of Medicine RADAR NORML
v t e

Retrieved from ‘https://openusaproject.com/w/index.php?title=Template:Regulation_of_therapeutic_goods_in_the_United_States&oldid=20740’